Akoya Biosciences (AKYA) Reports Q3 Loss, Lags Revenue Estimates

Akoya Biosciences (AKYA) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to loss of $0.26 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 5.26%. A quarter ago, it was expected that this tissue analysis provider would post a loss of $0.27 per share when it actually produced a loss of $0.27, delivering no surprise. Over the last four quarters, the company h ...